Within our DLB group there was some heterogeneity in phenotype: we observed that two clinically diagnosed DLB patients had markedly higher 123I-FP-CIT binding ratios for DAT and SERT than the other DLB patients. The gene discussed is SLC6A4; the disease is Lewy body dementia.